Light-enhanced VEGF121/rGel: A tumor targeted modality with vascular and immune-mediated efficacy
Anette WeyergangDepartment of Radiation Biology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University hospital, Norway. Electronic address: [email protected]Ane Sofie Viset FremstedalEllen SkarpenQian PengDepartment of Pathology, Norwegian Radium Hospital, Oslo University hospital, NorwayKhalid A. MohamedaliDepartment of Experimental Therapeutics, Immunopharmacology and Targeted Therapy Laboratory, M.D. Anderson Cancer Center, Houston, TX, United StatesMarius Strømbo EngLawrence H. CheungDepartment of Experimental Therapeutics, Immunopharmacology and Targeted Therapy Laboratory, M.D. Anderson Cancer Center, Houston, TX, United StatesMichael G. RosenblumDepartment of Experimental Therapeutics, Immunopharmacology and Targeted Therapy Laboratory, M.D. Anderson Cancer Center, Houston, TX, United StatesJohannes WaltenbergerDepartment of Cardiovascular Medicine, University of Münster, Münster, GermanyKristian Berg
2018en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0